Cargando…
Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
Autores principales: | Sen, Parikshit, R, Naveen, Nune, Arvind, Day, Jessica, Joshi, Mrudula, Agarwal, Vikas, Aggarwal, Rohit, Gupta, Latika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124998/ https://www.ncbi.nlm.nih.gov/pubmed/37124550 http://dx.doi.org/10.1016/S2665-9913(23)00066-8 |
Ejemplares similares
-
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol
por: Sen, Parikshit, et al.
Publicado: (2021) -
COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies
por: Gil‐Vila, Albert, et al.
Publicado: (2022) -
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey
por: Naveen, R., et al.
Publicado: (2023) -
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
por: Hoff, Leonardo Santos, et al.
Publicado: (2022) -
COVAD survey 2 long-term outcomes: unmet need and protocol
por: Fazal, Zoha Zahid, et al.
Publicado: (2022)